Page last updated: 2024-09-04

beta-lactams and bms-262084

beta-lactams has been researched along with bms-262084 in 1 studies

Compound Research Comparison

Studies
(beta-lactams)
Trials
(beta-lactams)
Recent Studies (post-2010)
(beta-lactams)
Studies
(bms-262084)
Trials
(bms-262084)
Recent Studies (post-2010) (bms-262084)
7,5791793,3951203

Protein Interaction Comparison

ProteinTaxonomybeta-lactams (IC50)bms-262084 (IC50)
Urokinase-type plasminogen activatorHomo sapiens (human)0.135
Cationic trypsinBos taurus (cattle)0.072
Coagulation factor XIHomo sapiens (human)0.0028
Trypsin-1Homo sapiens (human)0.0273
Trypsin-2Homo sapiens (human)0.05
Trypsin-3Homo sapiens (human)0.05
Plasminogen Rattus norvegicus (Norway rat)0.43
Tryptase alpha/beta-1Homo sapiens (human)0.0042
Tryptase deltaHomo sapiens (human)0.0042
Tryptase gammaHomo sapiens (human)0.0042

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burke, B; Kronenthal, DR; Qian, X; Saindane, MT; Zheng, B1

Other Studies

1 other study(ies) available for beta-lactams and bms-262084

ArticleYear
A stereoselective synthesis of BMS-262084, an azetidinone-based tryptase inhibitor.
    The Journal of organic chemistry, 2002, May-31, Volume: 67, Issue:11

    Topics: Anti-Asthmatic Agents; Azetidines; Ornithine; Piperazines; Serine Endopeptidases; Serine Proteinase Inhibitors; Stereoisomerism; Tryptases

2002